United States: June and Mid-Year 2013 IPO Market Review

The IPO market in June continued to produce a flow of new offerings at a torrid pace compared to recent years. The month ended with 19 IPOs—more than six times the paltry total of three in June 2012, when the IPO market was taking an early summer hiatus—and the highest June figure since the 19 in June 2005. The last week of June alone produced 10 offerings—the largest weekly total since the 11 IPOs in the first week of November 2007.

Gross proceeds of $3.64 billion in June failed to match the prior month's total of $4.56 billion but still represented the highest June figure since the $6.22 billion in June 2007. June's gross proceeds were buoyed by Coty's $1.0 billion IPO and HD Supply's $957 million IPO.

In total, the 70 IPOs in the first half of 2013 were six IPOs (9%) above the 64 in the first half of 2012 but 26% below the 95 in the first half of 2007—the recent high point of the IPO market, when the year ended with 193 IPOs. Gross proceeds for the first half of 2013 were $16.86 billion.

Year-to-date, 74% of all IPOs have been by emerging growth companies under the JOBS Act.

The average 2013 IPO has enjoyed a 17% first-day gain from its offering price—just eclipsing the 16% average first-day gain for full-year 2012. So far in 2013, 15 companies—21% of the total—have produced a first-day gain of at least 30%. An equal percentage of the year's IPOs have been "broken" (IPOs whose stock closes below the offering price on their opening day), compared to 20% in all of 2012 but still the second lowest level since 2007.

At June month-end, 42% of the year's IPOs were trading 25% or more above their offering price, including 23% up more than 50% from their offering price.

Through the first six months of 2013, the median deal size of $98.7 million is 5% higher than the $94.3 million in 2012. The median deal size of VC-backed companies is $78.8 million—the lowest level since the $72.0 million in 2007—while median deal size for non-VC backed companies is $230.0 million—58% higher than the prior ten-year average of $146.0 million. The median deal size for emerging growth companies, at $78.4 million, is less than a fifth of the $436.3 million median deal size for other companies.

The median annual revenue of IPO companies has decreased 33% from $133.6 million in 2012 to $90.1 million in 2013 to date—the lowest level since the $74.5 million in 2007. Emerging growth companies had median annual revenue of $53.5 million compared to $2.54 billion for other companies.

The percentage of profitable companies going public declined from 55% in 2012 to 44% in 2013 to date—the lowest level since the 26% in both 1999 and 2000. Only 30% of this year's life sciences and technology related IPO companies were profitable.

June IPO activity consisted of offerings by the following companies listed in the order they came to market:

  • RCS Capital, which is engaged in wholesale broker-dealer, investment banking and capital markets business activities, priced a downsized IPO at the midpoint of the range, and ended its first day of trading down 3%.
  • LightInTheBox, a Chinese global online retail company, priced at the midpoint of the range and appreciated 22% in first-day trading.
  • Textura, which provides on-demand project management software for the commercial construction industry, priced a twice upsized IPO at the high end of the range and ended its first trading day 39% above its offering price.
  • Data traffic management software maker Gigamon priced at the middle of the range and enjoyed a first-day gain of 50%.
  • Coty, a global fragrance and cosmetics conglomerate—the largest US-listed IPO in history for a consumer-products company, according to Dealogic—priced in the middle of the range and declined 1% on its first day of trading.
  • bluebird bio, a clinical-stage biotechnology company developing gene therapies for severe genetic and orphan diseases, priced an IPO upsized by just under 20% above the range and ended its first day of trading up 58%—the best first-day gain for any biotech company IPO since mid-2000.
  • PTC Therapeutics, a biopharmaceutical company focused on the discovery and development of orally administered, proprietary small-molecule drugs that target post transcriptional control processes, priced an IPO upsized by 21% within the range and saw a first-day gain of 10%.
  • Truett-Hurst, a wine sales, marketing and production company, priced an IPO through W.R. Hambrecht's OpenIPO auction-based process, and ended its first day of trading down 5%.
  • In-flight wireless connectivity provider Gogo priced at the top end of the range and ended its first day of trading down 6%.
  • Esperion Therapeutics, a biopharmaceutical company focused on the treatment for elevated levels of low-density lipoprotein cholesterol, priced an upsized IPO at the middle of the range and saw a first-day gain of 4%.
  • Luxoft, a global provider of software development services and IT solutions, priced at the midpoint of the range and appreciated 20% in first day trading.
  • NanoString Technologies, which develops, manufactures and sells diagnostic systems for the analysis of genomic information, priced below the range and declined 19% on its first day of trading.
  • Aratana Therapeutics, a development-stage biopharmaceutical company focused on pet therapeutics, priced a twice upsized IPO in line with a downwardly revised price and ended its first day of trading up 38%.
  • Private equity–backed CDW, a Fortune 500 provider of integrated information technology solutions, priced a downsized IPO at the low end of a downwardly revised range and increased 8% on its first day of trading.
  • HD Supply Holdings, one of the largest industrial and construction supplies distributors in North America, priced at the low end of the reduced range and ended its first day of trading up 4%.
  • Silvercrest Asset Management, a wealth management firm, priced below the range and saw a first-day gain of 8%.
  • Tremor Video, a provider of technology-driven video advertising solutions, continued the string of companies pricing below their original range and ended its first day of trading down 15%.
  • Noodles, a fast-casual restaurant operator, priced above an upwardly revised range and enjoyed a first-day gain of 104%.
  • The Netherlands-based Prosensa Holding, a biotech company engaged in the discovery and development of RNA-modulating therapeutics for the treatment of genetic disorders, priced an IPO upsized by 20% at the high end of the range and ended its first day of trading 48% above its offering price.

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.

To print this article, all you need is to be registered on Mondaq.com.

Click to Login as an existing user or Register so you can print this article.

Authors
Similar Articles
Relevancy Powered by MondaqAI
WilmerHale
WilmerHale
WilmerHale
WilmerHale
WilmerHale
 
In association with
Related Topics
 
Similar Articles
Relevancy Powered by MondaqAI
WilmerHale
WilmerHale
WilmerHale
WilmerHale
WilmerHale
Related Articles
 
Related Video
Up-coming Events Search
Tools
Print
Font Size:
Translation
Channels
Mondaq on Twitter
 
Register for Access and our Free Biweekly Alert for
This service is completely free. Access 250,000 archived articles from 100+ countries and get a personalised email twice a week covering developments (and yes, our lawyers like to think you’ve read our Disclaimer).
 
Email Address
Company Name
Password
Confirm Password
Position
Mondaq Topics -- Select your Interests
 Accounting
 Anti-trust
 Commercial
 Compliance
 Consumer
 Criminal
 Employment
 Energy
 Environment
 Family
 Finance
 Government
 Healthcare
 Immigration
 Insolvency
 Insurance
 International
 IP
 Law Performance
 Law Practice
 Litigation
 Media & IT
 Privacy
 Real Estate
 Strategy
 Tax
 Technology
 Transport
 Wealth Mgt
Regions
Africa
Asia
Asia Pacific
Australasia
Canada
Caribbean
Europe
European Union
Latin America
Middle East
U.K.
United States
Worldwide Updates
Registration (you must scroll down to set your data preferences)

Mondaq Ltd requires you to register and provide information that personally identifies you, including your content preferences, for three primary purposes (full details of Mondaq’s use of your personal data can be found in our Privacy and Cookies Notice):

  • To allow you to personalize the Mondaq websites you are visiting to show content ("Content") relevant to your interests.
  • To enable features such as password reminder, news alerts, email a colleague, and linking from Mondaq (and its affiliate sites) to your website.
  • To produce demographic feedback for our content providers ("Contributors") who contribute Content for free for your use.

Mondaq hopes that our registered users will support us in maintaining our free to view business model by consenting to our use of your personal data as described below.

Mondaq has a "free to view" business model. Our services are paid for by Contributors in exchange for Mondaq providing them with access to information about who accesses their content. Once personal data is transferred to our Contributors they become a data controller of this personal data. They use it to measure the response that their articles are receiving, as a form of market research. They may also use it to provide Mondaq users with information about their products and services.

Details of each Contributor to which your personal data will be transferred is clearly stated within the Content that you access. For full details of how this Contributor will use your personal data, you should review the Contributor’s own Privacy Notice.

Please indicate your preference below:

Yes, I am happy to support Mondaq in maintaining its free to view business model by agreeing to allow Mondaq to share my personal data with Contributors whose Content I access
No, I do not want Mondaq to share my personal data with Contributors

Also please let us know whether you are happy to receive communications promoting products and services offered by Mondaq:

Yes, I am happy to received promotional communications from Mondaq
No, please do not send me promotional communications from Mondaq
Terms & Conditions

Mondaq.com (the Website) is owned and managed by Mondaq Ltd (Mondaq). Mondaq grants you a non-exclusive, revocable licence to access the Website and associated services, such as the Mondaq News Alerts (Services), subject to and in consideration of your compliance with the following terms and conditions of use (Terms). Your use of the Website and/or Services constitutes your agreement to the Terms. Mondaq may terminate your use of the Website and Services if you are in breach of these Terms or if Mondaq decides to terminate the licence granted hereunder for any reason whatsoever.

Use of www.mondaq.com

To Use Mondaq.com you must be: eighteen (18) years old or over; legally capable of entering into binding contracts; and not in any way prohibited by the applicable law to enter into these Terms in the jurisdiction which you are currently located.

You may use the Website as an unregistered user, however, you are required to register as a user if you wish to read the full text of the Content or to receive the Services.

You may not modify, publish, transmit, transfer or sell, reproduce, create derivative works from, distribute, perform, link, display, or in any way exploit any of the Content, in whole or in part, except as expressly permitted in these Terms or with the prior written consent of Mondaq. You may not use electronic or other means to extract details or information from the Content. Nor shall you extract information about users or Contributors in order to offer them any services or products.

In your use of the Website and/or Services you shall: comply with all applicable laws, regulations, directives and legislations which apply to your Use of the Website and/or Services in whatever country you are physically located including without limitation any and all consumer law, export control laws and regulations; provide to us true, correct and accurate information and promptly inform us in the event that any information that you have provided to us changes or becomes inaccurate; notify Mondaq immediately of any circumstances where you have reason to believe that any Intellectual Property Rights or any other rights of any third party may have been infringed; co-operate with reasonable security or other checks or requests for information made by Mondaq from time to time; and at all times be fully liable for the breach of any of these Terms by a third party using your login details to access the Website and/or Services

however, you shall not: do anything likely to impair, interfere with or damage or cause harm or distress to any persons, or the network; do anything that will infringe any Intellectual Property Rights or other rights of Mondaq or any third party; or use the Website, Services and/or Content otherwise than in accordance with these Terms; use any trade marks or service marks of Mondaq or the Contributors, or do anything which may be seen to take unfair advantage of the reputation and goodwill of Mondaq or the Contributors, or the Website, Services and/or Content.

Mondaq reserves the right, in its sole discretion, to take any action that it deems necessary and appropriate in the event it considers that there is a breach or threatened breach of the Terms.

Mondaq’s Rights and Obligations

Unless otherwise expressly set out to the contrary, nothing in these Terms shall serve to transfer from Mondaq to you, any Intellectual Property Rights owned by and/or licensed to Mondaq and all rights, title and interest in and to such Intellectual Property Rights will remain exclusively with Mondaq and/or its licensors.

Mondaq shall use its reasonable endeavours to make the Website and Services available to you at all times, but we cannot guarantee an uninterrupted and fault free service.

Mondaq reserves the right to make changes to the services and/or the Website or part thereof, from time to time, and we may add, remove, modify and/or vary any elements of features and functionalities of the Website or the services.

Mondaq also reserves the right from time to time to monitor your Use of the Website and/or services.

Disclaimer

The Content is general information only. It is not intended to constitute legal advice or seek to be the complete and comprehensive statement of the law, nor is it intended to address your specific requirements or provide advice on which reliance should be placed. Mondaq and/or its Contributors and other suppliers make no representations about the suitability of the information contained in the Content for any purpose. All Content provided "as is" without warranty of any kind. Mondaq and/or its Contributors and other suppliers hereby exclude and disclaim all representations, warranties or guarantees with regard to the Content, including all implied warranties and conditions of merchantability, fitness for a particular purpose, title and non-infringement. To the maximum extent permitted by law, Mondaq expressly excludes all representations, warranties, obligations, and liabilities arising out of or in connection with all Content. In no event shall Mondaq and/or its respective suppliers be liable for any special, indirect or consequential damages or any damages whatsoever resulting from loss of use, data or profits, whether in an action of contract, negligence or other tortious action, arising out of or in connection with the use of the Content or performance of Mondaq’s Services.

General

Mondaq may alter or amend these Terms by amending them on the Website. By continuing to Use the Services and/or the Website after such amendment, you will be deemed to have accepted any amendment to these Terms.

These Terms shall be governed by and construed in accordance with the laws of England and Wales and you irrevocably submit to the exclusive jurisdiction of the courts of England and Wales to settle any dispute which may arise out of or in connection with these Terms. If you live outside the United Kingdom, English law shall apply only to the extent that English law shall not deprive you of any legal protection accorded in accordance with the law of the place where you are habitually resident ("Local Law"). In the event English law deprives you of any legal protection which is accorded to you under Local Law, then these terms shall be governed by Local Law and any dispute or claim arising out of or in connection with these Terms shall be subject to the non-exclusive jurisdiction of the courts where you are habitually resident.

You may print and keep a copy of these Terms, which form the entire agreement between you and Mondaq and supersede any other communications or advertising in respect of the Service and/or the Website.

No delay in exercising or non-exercise by you and/or Mondaq of any of its rights under or in connection with these Terms shall operate as a waiver or release of each of your or Mondaq’s right. Rather, any such waiver or release must be specifically granted in writing signed by the party granting it.

If any part of these Terms is held unenforceable, that part shall be enforced to the maximum extent permissible so as to give effect to the intent of the parties, and the Terms shall continue in full force and effect.

Mondaq shall not incur any liability to you on account of any loss or damage resulting from any delay or failure to perform all or any part of these Terms if such delay or failure is caused, in whole or in part, by events, occurrences, or causes beyond the control of Mondaq. Such events, occurrences or causes will include, without limitation, acts of God, strikes, lockouts, server and network failure, riots, acts of war, earthquakes, fire and explosions.

By clicking Register you state you have read and agree to our Terms and Conditions